Preliminary Scientific Programme
Day 1 | Tuesday, 2 May 2023
| From 7:30 a.m. | Registration Counter open | |
| 09:00 - 09:15 a.m. | Opening remarks | Klaus Pantel, Germany |
| Session 1 | Cancer Biology | |
| 09:15 - 09:45 a.m. | Mechanisms of Metastatic Awakening | Robert Weinberg, USA |
| 09:45 - 10:15 a.m. | Nicola Aceto, Switzerland | |
| 10:15 - 10:30 a.m. | Short talks selected from proffered abstracts | TBD |
| 10:30 - 10:45 a.m. | TBD | |
| 10:45 - 11:00 a.m. | Coffee Break | |
| Session 2 | Cancer Immunology | |
| 11:00 - 11:45 a.m. | Keynote by Tasuko Honjo, Nobel Laureate 2018, Japan | |
| 11:45 a.m. - 12:15 p.m. | Laurence Zitvogel, France | |
| 12:15 - 12:30 p.m. | Short talks selected from proffered abstracts | TBD |
| 12:30 - 12:45 p.m. | TBD | |
| 12:45 - 02:00 p.m. | Lunch Break | |
| Session 3 | Liquid Biopsy-Based Detection of Primary Cancer & Minimal Residual Cancer – Part I | |
| 02:00 - 02:30 p.m. | Clinical applications of MRD | Nick Papadopoulos, USA |
| 02:30 - 03:00 p.m. | Klaus Pantel, Germany | |
| 03:00 - 03:15 p.m. | Short talks selected from proffered abstracts | TBD |
| 03:15 - 03:30 p.m. | TBD | |
| 03:30 - 05:30 p.m. | Poster Session with Coffee | |
Day 2 | Wednesday, 3 May 2023
| Session 4 | Liquid Biopsy and Immuno-Oncology | |
| 09:00 - 09:30 a.m. | Luis Diaz, USA | |
| 09:30 - 10:00 a.m. | Catherine Alix-Panabières, France | |
| 10:00 - 10:15 a.m. | Short talks selected from proffered abstracts | TBD |
| 10:15 - 10:30 a.m. | TBD | |
| 10:30 - 11:00 a.m. | Coffee Break | |
| Session 5 | Immunotherapy for Prevention of Metastatic Progression – Part I | |
| 11:00 - 11:30 a.m. | Harnessing Natural Killer cells in cancer | Eric Vivier, France |
| 11:30 a.m. - 12:00 p.m. | Carsten Bokemeyer, Germany | |
| 12:00 - 12:15 p.m. | Short talks selected from proffered abstracts | TBD |
| 12:15 - 12:30 p.m. | TBD | |
| 12:30 - 02:00 p.m. | Lunch Break | |
| Session 6 | Liquid Biopsy-Based Detection of Primary Cancer & Minimal Residual Cancer – Part II | |
| 02:00 - 02:30 p.m. | Pushing the boundaries to expand diagnostic applications of circulating DNA | Nitzan Rosenfeld, UK |
| 02:30 - 03:00 p.m. | Howard Scher, USA | |
| 03:00- 03:30 p.m. | Circulating Tumor DNA for Minimal Residual Disease Detection and Risk-Stratified Recurrence Surveillance in Colorectal Cancer | Claus Andersen, Denmark |
| 03:30 - 03:45 p.m. | Short talks selected from proffered abstracts | TBD |
| 03:45 - 04:00 p.m. | TBD | |
| 04:00 - 06:00 p.m. | Poster Session with Coffee | |
Day 3 | Thursday, 4 May 2023
| Session 7 | Latest developments in Liquid biopsy-based monitoring of MRD | |
| 09:00 - 09:15 a.m. | TBD | |
| 09:15 - 09:30 a.m. | TBD | |
| 09:30 - 09:45 a.m. | TBD | |
| 09:45 - 10:00 a.m. | TBD | |
| 10:00 - 10:30 a.m. | Coffee Break | |
| Session 8 | Immunotherapy for prevention of metastatic progression – Part II | |
| 10:30 - 11:00 a.m. | Martin Reck, Germany | |
| 11:00 - 11:30 a.m. | Liquid biopsy & lung cancer immunotherapy: Between hope and hype in routine practice | Paul Hofman, France |
| 11:30 a.m. - 12:00 p.m. | Omics-driven identification of therapeutic resistance in metastatic melanoma patients receiving immune checkpoint inhibition | Christoffer Gebhardt, Germany |
| 12:00 - 12:30 p.m. | Young Investigator Awards | |
| 12:30 - 12:45 p.m. | Concluding Remarks | Klaus Pantel, Germany |